WAT 373.47 (+1.35%)
US9418481035• Medical Diagnostics & Research• Diagnostics & Research
Intro Stories Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. WAT

Waters (WAT) Competitor Comparison

We are evaluating the key criteria listed to compare Waters (WAT) against its competitors in the Diagnostics & Research industry.

Market Capitalization

10 / 58

Gross Profits

13 / 52

Total Revenue

15 / 57

EBITDA

11 / 56

Free Cashflow

15 / 56

Quick Ratio

35 / 57

Earnings per Share

4 / 56

Dividend yield

0 / 9

Total Cash

19 / 57

Performance 3 years

10 / 58

Performance 5 years

9 / 58

Performance 10 years

15 / 58

Linearity 3 years

4 / 58

Linearity 5 years

40 / 58

Linearity 10 years

52 / 58

Total Rank

5 / 58

Dividend Rank

4 / 58

Valuation Rank

39 / 58

Piotroski Rank

36 / 58

Muliplier Rank

20 / 58

Muliplier Rank - WAT ranking 20 / 58

These are the competitors of Waters in the industry Diagnostics & Research ranked by muliplier rank
1. Global Cord Blood CO
1
2. Quest Diagnostics DGX
0.8
3. Laboratory Corp of America Holdings LH
0.8
4. Interpace Biosciences IDXG
0.6
5. Organovo Holdings ONVO
0.6
6. Ortho Clinical Diagnostics Holdings OCDX
0.6
7. IQVIA Holdings IQV
0.6
8. PerkinElmer PKI
0.6
9. bioAffinity Technologies BIAF
0.6
10. Qiagen QGEN
0.6
11. Syneos Health SYNH
0.6
12. Trinity Biotech TRIB
0.6
13. Inotiv NOTV
0.6
14. Exagen XGN
0.6
15. RadNet RDNT
0.6
16. Icon ICLR
0.6
17. Charles River Laboratories CRL
0.6
18. Illumina ILMN
0.6
19. Danaher DHR
0.5
20. Waters WAT
0.4
21. Fulgent Genetics FLGT
0.4
22. Psychemedics PMD
0.4
23. Thermo Fisher Scientific TMO
0.4
24. Neogen NEOG
0.2
25. NeoGenomics NEO
0.2
26. Neuronetics STIM
0.2
27. Olink Holding OLK
0.2
28. Pacific Biosciences of California PACB
0.2
29. Personalis PSNL
0.2
30. Precipio PRPO
0.2
31. Prenetics Global PRE
0.2
32. Agilent Technologies A
0.2
33. Sera Prognostics SERA
0.2
34. Sotera Health SHC
0.2
35. Twist Bioscience TWST
0.2
36. SeqLL SQL
0.2
37. Anixa Biosciences ANIX
0.2
38. Aspira Womens Health AWH
0.2
39. Biodesix BDSX
0.2
40. Bioventus BVS
0.2
41. CareDx CDNA
0.2
42. Co-Diagnostics CODX
0.2
43. DarioHealth DRIO
0.2
44. DexCom DXCM
0.2
45. Enzo Biochem ENZ
0.2
46. Exact Sciences EXAS
0.2
47. Guardant Health GH
0.2
48. Heska HSKA
0.2
49. IDEXX Laboratories IDXX
0.2
50. Lantheus Holdings LNTH
0.2
51. MaxCyte MXCT
0.2
52. MDxHealth MDXH
0.2
53. Medpace Holdings MEDP
0.2
54. Meridian Bioscience VIVO
0.2
55. Mettler-Toledo MTD
0.2
56. Myriad Genetics MYGN
0.2
57. Natera NTRA
0.2
58. National Research NRC
0.2
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.